Judges Scientific Regulatory News (JDG)

Judges Scientific plc (the "Company")

8 April 2014

Director/PDMR Shareholding

Judges Scientific has today been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 7 April 2014 by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:

A total of five Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,410 Ordinary Shares representing 15.53 per cent of the issued Ordinary share capital. In addition, he holds options over 1,775 Ordinary Shares under the Company's Share Option Plans.

A total of five Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company. His resulting interest in the Company is 57,929 Ordinary Shares representing 0.98 per cent of the issued Ordinary share capital. In addition, he holds options over 7,875 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 2400.0p per Ordinary Share. Purchases of a further 343 Ordinary Shares were made on the same date and at the same price on behalf of 59 other members of staff under the Plan.

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 020 7930 0777 or 07775 896 491

Website:

Judges Scientific: www.judges.uk.com